Merck KGaA

Insider Reports History

Location
Darmstadt, Germany
Signature
/s/ Christian Uhrich, Authorized signatory of Merck KGaA, Darmstadt, Germany
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Merck KGaA:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xilio Therapeutics, Inc. 10%+ Owner Common Stock 680,825 $565,085 $0.8300 26 Oct 2021 Indirect
Xilio Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 26 Oct 2021 Indirect
Xilio Therapeutics, Inc. 10%+ Owner Series C Preferred Srock 0 26 Oct 2021 Indirect

Insider Reports Filed by Merck KGaA

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XLO Xilio Therapeutics, Inc. 26 Oct 2021 4 $0 4 10%+ Owner 26 Oct 2021, 17:06
XLO Xilio Therapeutics, Inc. 21 Oct 2021 0 $0 3 10%+ Owner 21 Oct 2021, 20:50